114 related articles for article (PubMed ID: 19198124)
1. [Therapeutic strategy against multiple sclerosis].
Suzumura A
Rinsho Shinkeigaku; 2008 Nov; 48(11):937-9. PubMed ID: 19198124
[TBL] [Abstract][Full Text] [Related]
2. Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice.
Shijie J; Takeuchi H; Yawata I; Harada Y; Sonobe Y; Doi Y; Liang J; Hua L; Yasuoka S; Zhou Y; Noda M; Kawanokuchi J; Mizuno T; Suzumura A
Tohoku J Exp Med; 2009 Feb; 217(2):87-92. PubMed ID: 19212100
[TBL] [Abstract][Full Text] [Related]
3. Midkine and multiple sclerosis.
Takeuchi H
Br J Pharmacol; 2014 Feb; 171(4):931-5. PubMed ID: 24460675
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors.
Yawata I; Takeuchi H; Doi Y; Liang J; Mizuno T; Suzumura A
Life Sci; 2008 May; 82(21-22):1111-6. PubMed ID: 18452953
[TBL] [Abstract][Full Text] [Related]
5. Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.
Trinschek B; Luessi F; Gross CC; Wiendl H; Jonuleit H
Int J Mol Sci; 2015 Jul; 16(7):16330-46. PubMed ID: 26193267
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in multiple sclerosis and myasthenia gravis.
Danikowski KM; Jayaraman S; Prabhakar BS
J Neuroinflammation; 2017 Jun; 14(1):117. PubMed ID: 28599652
[TBL] [Abstract][Full Text] [Related]
7. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
8. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
[TBL] [Abstract][Full Text] [Related]
9. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
[TBL] [Abstract][Full Text] [Related]
10. Macrophages and neurodegeneration.
Hendriks JJ; Teunissen CE; de Vries HE; Dijkstra CD
Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
[TBL] [Abstract][Full Text] [Related]
11. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
12. Deleterious versus protective autoimmunity in multiple sclerosis.
Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
[TBL] [Abstract][Full Text] [Related]
13. Glutamate, T cells and multiple sclerosis.
Levite M
J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
[TBL] [Abstract][Full Text] [Related]
14. Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells.
Sonobe Y; Li H; Jin S; Kishida S; Kadomatsu K; Takeuchi H; Mizuno T; Suzumura A
J Immunol; 2012 Mar; 188(6):2602-11. PubMed ID: 22323540
[TBL] [Abstract][Full Text] [Related]
15. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
Biernacki K; Antel JP; Blain M; Narayanan S; Arnold DL; Prat A
Arch Neurol; 2005 Apr; 62(4):563-8. PubMed ID: 15824253
[TBL] [Abstract][Full Text] [Related]
16. Interferon beta in the treatment of multiple sclerosis: mechanisms of action.
Yong VW; Chabot S; Stuve O; Williams G
Neurology; 1998 Sep; 51(3):682-9. PubMed ID: 9748010
[TBL] [Abstract][Full Text] [Related]
17. [Progress in unravelling the etiology of multiple sclerosis].
Matsui M
Rinsho Shinkeigaku; 2008 Nov; 48(11):849-52. PubMed ID: 19198098
[TBL] [Abstract][Full Text] [Related]
18. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells.
Hall BM; Tran GT; Robinson CM; Hodgkinson SJ
Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104
[TBL] [Abstract][Full Text] [Related]
19. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
[TBL] [Abstract][Full Text] [Related]
20. (-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.
Alberti TB; Barbosa WL; Vieira JL; Raposo NR; Dutra RC
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
